NurExone Biologic Inc. Announces Fourth Quarter and Full-Year 2024 Financial Results and Provides Corporate Update
TORONTO and HAIFA, Israel, April 10, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic…
PRA Group Announces Leadership Succession Plan
Martin Sjolund appointed President and Chief Executive Officer, effective June 17, 2025…
Edesa Biotech Announces Chief Financial Officer Transition
TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq:EDSA), a…
Acceleware Ltd. Reports Fourth Quarter 2024 Financial and Operating Results
CALGARY, Alberta, April 02, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or…
Ambow Files Annual Report on Form 20-F for Fiscal Year 2024
March 28, 2025 16:02 ET | Source: Ambow Education Holding Ltd. CUPERTINO,…
IOC expresses deep sadness at the death of IOC Honorary Member Olegario Vzquez Raa
28 March 2025 - It is with profound sorrow that the International Olympic…
Inventronics Announces 2024 Year End Financial Results
March 27, 2025 17:00 ET | Source: Inventronics Limited CALGARY, Alberta, March…
YXT.com Reports Full Year 2024 Unaudited Financial Results
SUZHOU, China, March 28, 2025 (GLOBE NEWSWIRE) -- YXT.com Group Holding Limited…
Lone Wolf Champions Arts and Culture at Serendipity Arts Festival 2024
Lone Wolf, the trailblazing premium brand by Onkara Beverages and Hospitality, proudly…
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update…